Auristone bags $5.4m in Elev8.vc-led funding round

The startup will use the capital to promote its flagship product.

Auristone has secured $5.4m (US$4m) capital from its latest seed funding round led by venture capital firm Elev8.vc.

SEEDS Capital and existing investor Genedant joined the funding round.

The biotech startup focuses on promoting epigenomics in healthcare through its flagship molecular profiling test, “EPI-CALL,” which assists doctors and late-stage cancer patients navigate different therapy options.

The startup will use the raised funds to expand its clinical collaborations and promote EPI-CALL in the market by working with regional genomic companies.

Follow the link for more news on

startups

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia